Format

Send to

Choose Destination
JAMA. 2012 Sep 5;308(9):869-70. doi: 10.1001/jama.2012.9658.

The safety risks of innovation: the FDA's Expedited Drug Development Pathway.

Author information

1
Institute for Safe Medication Practices, Alexandria, Virginia, USA.
PMID:
22948694
DOI:
10.1001/jama.2012.9658
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Silverchair Information Systems
Loading ...
Support Center